Synopsys Balance Sheet Health

Financial Health criteria checks 6/6

Synopsys has a total shareholder equity of $9.0B and total debt of $15.6M, which brings its debt-to-equity ratio to 0.2%. Its total assets and total liabilities are $13.1B and $4.1B respectively. Synopsys's EBIT is $1.4B making its interest coverage ratio -42.6. It has cash and short-term investments of $4.1B.

Key information

0.2%

Debt to equity ratio

US$15.60m

Debt

Interest coverage ratio-42.6x
CashUS$4.05b
EquityUS$9.02b
Total liabilitiesUS$4.05b
Total assetsUS$13.07b

Recent financial health updates

Recent updates

Synopsys Q4: Anticipating Revenue Deceleration In FY 2025; Remain 'Sell'

Dec 05

Should You Be Adding Synopsys (NASDAQ:SNPS) To Your Watchlist Today?

Nov 17
Should You Be Adding Synopsys (NASDAQ:SNPS) To Your Watchlist Today?

Is Synopsys (NASDAQ:SNPS) Using Too Much Debt?

Nov 04
Is Synopsys (NASDAQ:SNPS) Using Too Much Debt?

At US$507, Is It Time To Put Synopsys, Inc. (NASDAQ:SNPS) On Your Watch List?

Oct 21
At US$507, Is It Time To Put Synopsys, Inc. (NASDAQ:SNPS) On Your Watch List?

Synopsys Stock: Double-Digit Annual Returns Likely

Oct 07

Earnings Tell The Story For Synopsys, Inc. (NASDAQ:SNPS)

Sep 26
Earnings Tell The Story For Synopsys, Inc. (NASDAQ:SNPS)

Synopsys: Fantastic Company With One Shortcoming

Aug 24

Is Synopsys, Inc. (NASDAQ:SNPS) Worth US$549 Based On Its Intrinsic Value?

Aug 18
Is Synopsys, Inc. (NASDAQ:SNPS) Worth US$549 Based On Its Intrinsic Value?

Here's Why Synopsys (NASDAQ:SNPS) Has Caught The Eye Of Investors

Jul 25
Here's Why Synopsys (NASDAQ:SNPS) Has Caught The Eye Of Investors

Synopsys: Market Position Boosted With Ansys Acquisition

Jul 17

Is Synopsys (NASDAQ:SNPS) A Risky Investment?

Jul 11
Is Synopsys (NASDAQ:SNPS) A Risky Investment?

Synopsys, Inc.'s (NASDAQ:SNPS) P/E Still Appears To Be Reasonable

Jun 14
Synopsys, Inc.'s (NASDAQ:SNPS) P/E Still Appears To Be Reasonable

What Is Synopsys, Inc.'s (NASDAQ:SNPS) Share Price Doing?

May 27
What Is Synopsys, Inc.'s (NASDAQ:SNPS) Share Price Doing?

Synopsys: Reasons To Hold Despite Perceived Overvaluation

May 23

Synopsys: Selling On The Cheap Ahead Of The Ansys Deal

May 17

Is Now The Time To Put Synopsys (NASDAQ:SNPS) On Your Watchlist?

Apr 16
Is Now The Time To Put Synopsys (NASDAQ:SNPS) On Your Watchlist?

Synopsys: Potential Further Upside For Compounding Machine

Apr 04

Synopsys (NASDAQ:SNPS) Has A Rock Solid Balance Sheet

Apr 02
Synopsys (NASDAQ:SNPS) Has A Rock Solid Balance Sheet

Synopsys: A Quality Compounder With A Stretched Valuation

Mar 25

Synopsys (NASDAQ:SNPS) Might Have The Makings Of A Multi-Bagger

Mar 20
Synopsys (NASDAQ:SNPS) Might Have The Makings Of A Multi-Bagger

Synopsys Q1 Earnings Preview: Why The ANSYS Acquisition May Destroy Shareholder Value

Feb 21

With Synopsys, Inc. (NASDAQ:SNPS) It Looks Like You'll Get What You Pay For

Jan 23
With Synopsys, Inc. (NASDAQ:SNPS) It Looks Like You'll Get What You Pay For

What Is Synopsys, Inc.'s (NASDAQ:SNPS) Share Price Doing?

Jan 09
What Is Synopsys, Inc.'s (NASDAQ:SNPS) Share Price Doing?

Here's Why Synopsys (NASDAQ:SNPS) Has Caught The Eye Of Investors

Dec 28
Here's Why Synopsys (NASDAQ:SNPS) Has Caught The Eye Of Investors

Financial Position Analysis

Short Term Liabilities: SNPS's short term assets ($6.5B) exceed its short term liabilities ($2.7B).

Long Term Liabilities: SNPS's short term assets ($6.5B) exceed its long term liabilities ($1.4B).


Debt to Equity History and Analysis

Debt Level: SNPS has more cash than its total debt.

Reducing Debt: SNPS's debt to equity ratio has reduced from 3.4% to 0.2% over the past 5 years.

Debt Coverage: SNPS's debt is well covered by operating cash flow (9018.8%).

Interest Coverage: SNPS earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 22:49
End of Day Share Price 2024/12/20 00:00
Earnings2024/10/31
Annual Earnings2024/10/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Synopsys, Inc. is covered by 35 analysts. 21 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Joseph VruwinkBaird
Ishan MajumdarBaptista Research
Gary MobleyBenchmark Company